(UroToday.com) In plenary presentation in the Progress and Promise in Treatment Personalization for Advanced Prostate Cancer session at the 2021 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), Dr. Karen Autio discussed ways in which we can harness the immune system to treat prostate cancer, emphasizing the role of immune checkpoint inhibitors in prostate cancer.